Matsuo Y - Search Results

1

GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines.

Yu W, Inoue J, Imoto I, Matsuo Y, Karpas A, Inazawa J. Yu W, et al. Among authors: matsuo y. J Hum Genet. 2003;48(6):331-335. doi: 10.1007/s10038-003-0026-2. Epub 2003 Apr 29. J Hum Genet. 2003. PMID: 12721791

2

Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Inoue J, Otsuki T, Hirasawa A, Imoto I, Matsuo Y, Shimizu S, Taniwaki M, Inazawa J. Inoue J, et al. Among authors: matsuo y. Am J Pathol. 2004 Jul;165(1):71-81. doi: 10.1016/S0002-9440(10)63276-2. Am J Pathol. 2004. PMID: 15215163 Free PMC article.

3

[T cell differentiation model based on the expression of T cell receptor chains and genes--study in the human leukemia/lymphoma cell lines].

Matsuo Y, Ariyasu T, Minowada J. Matsuo Y, et al. Hum Cell. 1990 Oct;3(3):201-12. Hum Cell. 1990. PMID: 2076429 Japanese.

4

Transcription factor expression in cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.

Matsuo Y, Drexler HG, Harashima A, Okochi A, Shimizu N, Orita K. Matsuo Y, et al. Hum Cell. 2004 Jun;17(2):85-92. doi: 10.1111/j.1749-0774.2004.tb00079.x. Hum Cell. 2004. PMID: 15369140

5

Establishment of leukemia cell lines, BALM-6, BALM-7 and BALM-8 with B-cell characteristics from a patient with acute lymphoblastic leukemia.

Matsuo Y, Adachi T, Tsubota T, Minowada J. Matsuo Y, et al. Hum Cell. 1992 Jun;5(2):187-90. Hum Cell. 1992. PMID: 1390421

6

Establishment and characterization of new B-cell precursor leukemia cell line NALM-35.

Matsuo Y, Drexler HG, Harashima A, Fujii N, Ishimaru F, Orita K. Matsuo Y, et al. Hum Cell. 2002 Dec;15(4):215-23. doi: 10.1111/j.1749-0774.2002.tb00118.x. Hum Cell. 2002. PMID: 12889857

7

Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia.

Matsuo Y, Ariyasu T, Adachi T, Tsubota T, Minowada J. Matsuo Y, et al. Hum Cell. 1991 Dec;4(4):339-42. Hum Cell. 1991. PMID: 1667895

8

Bi-phenotypic t(9;22)-positive leukemia cell lines from a patient with acute leukemia: NALM-20, established at the onset; and NALM-21, NALM-22 and NALM-23, established after relapse.

Matsuo Y, Ariyasu T, Ohmoto E, Kimura I, Minowada J. Matsuo Y, et al. Hum Cell. 1991 Dec;4(4):335-8. Hum Cell. 1991. PMID: 1817649

9

Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.

Matsuo Y, Drexler HG. Matsuo Y, et al. Leuk Res. 2003 Oct;27(10):935-45. doi: 10.1016/s0145-2126(03)00024-9. Leuk Res. 2003. PMID: 12860014

10

Novel B-cell acute lymphoblastic leukemia sister cell lines BALM 19-23 and BALM-26 with interclonal proliferative and phenotypic heterogeneity from a patient with hypercalcemia.

Matsuo Y, Drexler HG, Kojima K, Sugimoto A, Harashima A, Okochi A, Hara M, Orita K. Matsuo Y, et al. Hum Cell. 2002 Sep;15(3):160-70. doi: 10.1111/j.1749-0774.2002.tb00110.x. Hum Cell. 2002. PMID: 12703546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,354 results

Search Page

Filters